Sweet v. United States

528 F. Supp. 1068, 1981 U.S. Dist. LEXIS 16548
CourtDistrict Court, D. South Dakota
DecidedDecember 28, 1981
DocketCiv. 79-3056
StatusPublished
Cited by4 cases

This text of 528 F. Supp. 1068 (Sweet v. United States) is published on Counsel Stack Legal Research, covering District Court, D. South Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sweet v. United States, 528 F. Supp. 1068, 1981 U.S. Dist. LEXIS 16548 (D.S.D. 1981).

Opinion

MEMORANDUM OPINION

DONALD J. PORTER, District' Judge.

CASE SUMMARY

Calvin Sweet brought suit against the United States under the Federal Tort Claims Act, 28 U.S.C. §§ 1346(b), 2671 et seq., to recover for injuries sustained allegedly as a result of the Army’s post-dis *1070 charge negligence in failing to advise him that he was given lysergic acid diethylamide (LSD) as part of a chemical warfare experiment at Edgewood Arsenal, Maryland, in 1957, and in failing to provide him with the necessary follow-up treatment and care. The United States contends that the suit is barred by the two-year statute of limitations provision of the Federal Tort Claims Act, 28 U.S.C. § 2401(b), and claims “intra-military immunity” under the rule of Feres v. United States, 340 U.S. 135, 71 S.Ct. 153, 95 L.Ed. 152 (1950). The United States further contends that Sweet failed to prove any breach of the standard of care or that such a breach was the proximate cause of his injuries. For the reasons which follow, the Court finds that recovery against the United States is barred under both the statute of limitations provision of the Federal Tort Claims Act, and under the Feres doctrine of intra-military immunity. In addition, the Court finds that Sweet failed to prove by a preponderance of the evidence that the failure of the United States to provide follow-up care caused his present mental condition or aggravated an earlier mental condition.

FACTUAL BACKGROUND

In 1957, Calvin Sweet was a nineteen-year old private in the United States Army, stationed at Fort Stewart, Georgia. Responding to a posted notice, Sweet volunteered to participate in a series of chemical warfare experiments to be conducted at the United States Army Chemical Center at Edgewood Arsenal, Maryland. The experiments were designed to test and develop methods for the Army’s utilization of, and defense against, chemical warfare agents, including lysergic acid diethylamide (LSD).

On or about September 1, 1957, Sweet was assigned to temporary duty at Edge-wood Arsenal for approximately one month. As part of the experiments, Sweet was asked on three occasions to drink a clear, odorless substance. Sweet was told that the substance would cause him no harm. Upon drinking the substance, Sweet was supposed to describe to an Army doctor the sensations he was experiencing. The records relating to Sweet’s participation in the experiments, however, do not indicate precisely what chemical substance, if any, was administered to him.

Sweet left the Army in March, 1959, but reenlisted in January, 1961. Upon re-enlistment, Sweet was assigned to a tour of duty in Germany. Sweet, however, was discharged in January of 1962, following an incident for which he was admitted to an Army hospital in Germany because of what an Army doctor described as an “acute episode of violent, uncontrollable behavior while in an intoxicated state.” Thereafter, Sweet’s commanding officer recommended that Sweet be voluntarily discharged because of recurring nervous spells.

On August 4, 1976, Sweet applied for benefits from the Veterans Administration based on, inter alia, the nervous condition which he claimed resulted from his participation in a drug experiment during his first enlistment. The VA determined that Sweet’s condition was not compensable. That decision was reversed on appeal and in June, 1977 Sweet was awarded a fifty percent disability retroactive to the date of his claim. 1

On November 21, 1978, Sweet filed an administrative claim with the Department of the Army, which was denied. Thereafter, Sweet filed this suit in the District Court for the District of South Dakota, Central Division.

I

STATUTE OF LIMITATIONS

Under the Federal Tort Claims Act, a tort claim against the United States is *1071 barred “unless it is presented in writing to the appropriate federal agency within two years after such claim accrues. . . . ” 28 U.S.C. § 2401(b). Sweet filed his administrative claim with the Department of the Army on November 21, 1978. Consequently, for Sweet’s claim to be time-barred, it must have accrued prior to November 21, 1976.

Sweet contends that a claim does not “accrue” until the claimant knows of the existence of an injury and its cause. See United States v. Kubrick, 444 U.S. 111, 100 S.Ct. 352, 62 L.Ed.2d 259 (1979). Sweet argues that he did not know the cause of his injuries until October 16, 1978, when the Army impliedly advised him that he had been given LSD at Edgewood Arsenal in 1957. 2 Although Sweet suspected long before October, 1978, that his injuries were linked to a drug he had received at Edge-wood Arsenal, he argues that a mere belief or suspicion as to the cause of his injuries is not sufficient to commence the running of the statute of limitations. See Tyminski v. United States, 481 F.2d 257 (3d Cir. 1973). The United States, however, contends that there is ample evidence that Sweet knew of his injuries and their probable cause in September, 1957, or at the very latest, in August, 1976, and therefore Sweet’s claim is time-barred.

The Supreme Court recently discussed the limitations under the Federal Tort Claims Act in United States v. Kubrick, supra. In Kubrick, a veteran had received treatment in a VA hospital in 1968 for a bone infection. Following surgery, a VA doctor irrigated the infected area with neomycin, an antibiotic, until the infection cleared. Shortly after his discharge from the hospital Kubrick noticed a ringing sensation in his ears and some loss of hearing. In 1969, an ear specialist informed Kubrick that it was highly possible that the hearing loss was a result of the neomycin treatment at the VA hospital. Kubrick filed for disability benefits, but the VA denied his claim. In the course of pursuing his administrative appeal in 1971, another ear specialist informed Kubrick that the neomycin treatment had, in fact, caused his hearing loss and the treatment should not have been administered. Kubrick subsequently filed suit under the Federal Tort Claims Act.

The Supreme Court held that Kubrick’s claim accrued in 1969 when he was first advised of the probable link between the neomycin treatment and his subsequent loss of hearing. The Court reasoned that the statute of limitations is triggered when a plaintiff possesses “the critical facts that he has been hurt and who inflicted the injury,” and not at a later date when he learns that *1072 his injury was negligently inflicted. 444 U.S. at 122-23, 100 S.Ct. at 359-360.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

M.M.H. v. United States
966 F.2d 285 (Seventh Circuit, 1992)
Scott v. Casey
562 F. Supp. 475 (N.D. Georgia, 1983)
Calvin G. Sweet v. United States
687 F.2d 246 (Eighth Circuit, 1982)
Gaspard v. United States
544 F. Supp. 55 (E.D. Louisiana, 1982)

Cite This Page — Counsel Stack

Bluebook (online)
528 F. Supp. 1068, 1981 U.S. Dist. LEXIS 16548, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sweet-v-united-states-sdd-1981.